
Oxaplatin is a brand of oxaliplatin, a platinum-based cytotoxic chemotherapy medicine. It interferes with cancer-cell DNA, which helps slow or stop the growth of rapidly dividing cancer cells. The product discussed here is Oxaplatin 100 mg vial on Vezeeta.
| Feature | Details |
|---|---|
| Brand | Oxaplatin / اوكسابلاتين |
| Active ingredient | Oxaliplatin |
| Strength discussed | 100 mg vial, 20 mL |
| Form | Vial for intravenous infusion after dilution |
| Main use | Treatment of colorectal cancer as part of combination chemotherapy |
Oxaliplatin may be supplied in different vial strengths and by different manufacturers. The total dose is not chosen by vial size alone; it is calculated for each patient using body surface area, kidney function, blood counts, side effects, and the full chemotherapy protocol.
Oxaplatin is used with other cancer medicines, most commonly fluorouracil and leucovorin, for stage III colon cancer after surgery and for advanced colorectal cancer. If you are starting or comparing treatment plans, you can book an oncologist on Vezeeta. For more background about symptoms and stages, this Vezeeta article on colon cancer may also be useful.
Oxaplatin is not used for ordinary stomach upset, irritable bowel symptoms, piles, bowel inflammation, or cancer prevention. It should only be given when an oncology specialist decides that the expected benefit is greater than the risks.
A common adult oxaliplatin regimen for colorectal cancer is 85 mg/m² by intravenous infusion over about 2 hours every 2 weeks, usually with fluorouracil and leucovorin. Adjuvant treatment after surgery may continue for about 6 months, while treatment for advanced disease depends on response and tolerability.
Oxaplatin is given in a hospital or specialized chemotherapy unit. It must be diluted before infusion, commonly in 5% dextrose. It should not be diluted with normal saline or chloride-containing solutions and should not be prepared or administered using aluminum-containing equipment.
Food does not directly affect Oxaplatin because it is given by IV infusion, not by mouth. However, nausea can occur, so the oncology team may give anti-nausea medicines before treatment and advise small meals and good fluid intake when suitable.
If a chemotherapy appointment is missed, contact the oncology unit immediately. Do not try to replace the dose yourself or change the cycle schedule without medical supervision.
Oxaplatin does not usually produce an immediate noticeable effect. Response is assessed over several cycles using scans, symptoms, physical examination, blood tests, and sometimes tumor markers. Some side effects, such as cold-triggered tingling, jaw discomfort, or throat tightness sensation, may appear during or shortly after the infusion.
Common side effects include nausea, vomiting, diarrhea, mouth sores, tiredness, low white blood cells, low platelets, anemia, abnormal liver tests, numbness, tingling, burning pain, and sensitivity to cold drinks or cold air.
Cold sensitivity may last a few days after treatment, but nerve symptoms can become more persistent after repeated cycles. Some patients improve after dose reduction or stopping treatment, but neuropathy may last months or longer in some cases.
Seek urgent help for trouble breathing, throat tightness, swelling of the face or lips, chest pain, fainting, irregular heartbeat, fever, chills, uncontrolled diarrhea or vomiting, black stools, blood in urine, severe weakness, confusion, seizures, vision changes, severe muscle pain with dark urine, or worsening shortness of breath.
Oxaplatin must not be used in anyone with a serious allergy to oxaliplatin or other platinum medicines unless a specialist decides otherwise in a controlled setting. Tell your doctor about kidney disease, liver problems, lung disease, heart rhythm problems, electrolyte disturbances, bleeding disorders, infection, numbness or neuropathy, or previous severe chemotherapy reactions.
Blood counts, kidney function, liver function, electrolytes, and neurological symptoms are monitored during treatment. Driving or operating machinery may be unsafe if dizziness, vision problems, weakness, or neuropathy occur.
Tell the oncology team about all prescription medicines, over-the-counter medicines, vitamins, and herbal products. Important issues include blood thinners such as warfarin, medicines that increase bleeding risk, drugs that can affect heart rhythm, medicines that lower potassium or magnesium, other chemotherapy medicines, and live vaccines during periods of reduced immunity.
In the infusion line, oxaliplatin has compatibility rules: it should not be mixed with alkaline solutions or chloride-containing diluents, and fluorouracil or leucovorin administration should follow the protocol set by the chemotherapy team.
Oxaplatin can harm an unborn baby. Pregnancy testing may be required before treatment. Females who can become pregnant should use effective contraception during treatment and for 9 months after the final dose. Males with female partners who can become pregnant should use effective contraception during treatment and for 6 months after the final dose.
Breastfeeding is not recommended during treatment and for 3 months after the final dose because of the potential for serious harm to the infant. Patients who may want children in the future should ask about fertility preservation before treatment starts.
No. Oxaplatin is not a daily medicine and is not taken by mouth. It is given in cycles, often every 2 weeks in many colorectal cancer regimens. Long-term continuation depends on cancer type, stage, treatment goal, response, blood counts, neuropathy, kidney function, and overall tolerance. Treatment may be delayed, reduced, or stopped if side effects become unsafe.
Alternatives depend on the cancer stage, previous treatment, genetic and molecular testing, general health, and treatment goal. Options may include other chemotherapy medicines, targeted therapy, immunotherapy for selected tumors, surgery, radiotherapy, or best supportive care. Do not substitute another medicine for Oxaplatin without your oncologist.
The price and availability of Oxaplatin 100 mg vial in Egypt can change. Check the verified product page for Oxaplatin on Vezeeta or ask your hospital pharmacy. Chemotherapy costs may also include infusion-unit fees, lab tests, anti-nausea medicines, and related cancer medicines.
Oxaliplatin is a platinum chemotherapy medicine used mainly for colorectal cancer in combination with other anti-cancer medicines.
It is used for stage III colon cancer after surgery and for advanced colon or rectal cancer, usually with fluorouracil and leucovorin.
It damages DNA inside cancer cells, interferes with cell division, and helps kill rapidly growing cells.
It is administered as an intravenous infusion by trained staff after dilution, commonly over about 2 hours.
Some effects last days, such as nausea or cold sensitivity. Neuropathy can last longer and may become persistent after repeated cycles.
Follow anti-nausea instructions, avoid cold drinks and cold air after treatment, report symptoms early, keep lab appointments, and never adjust treatment without the oncology team.
It often occurs during the first few days after infusion, but the duration varies. Worsening or persistent tingling should be reported.
Effectiveness depends on cancer stage, regimen, tumor biology, and patient factors. It is an established part of colorectal cancer treatment protocols.
Leucovorin is used with fluorouracil to strengthen fluorouracil’s anti-cancer effect. Oxaliplatin, fluorouracil, and leucovorin are commonly combined in regimens such as FOLFOX.
Stopping may be needed for cancer progression, severe allergy, serious blood-count problems, severe neuropathy, organ toxicity, or completion of the planned treatment course.
Platinum-related material can remain in the body longer than the infusion time. The practical treatment schedule is based on cycles, side effects, and lab recovery rather than a simple number of days.
Oxaliplatin is incompatible with chloride-containing solutions such as normal saline, so chemotherapy protocols commonly use 5% dextrose for dilution.
The dose is usually calculated in mg/m² using body surface area, then adjusted for kidney function, blood counts, toxicity, and the treatment protocol.
The information in this article is provided for general health education and does not replace medical advice from a doctor or pharmacist. Do not start, stop, or change the dose of any medication without consulting a qualified healthcare professional.
Consultant in Oncology ,Hematology and Nuclear Medicine, Al-Azhar Medicine
Lecturer Clinical Oncology Faculty of Medicine Alexandria University
Consultant and MD in Oncology and Nuclear Medicine, Cairo University, Kasr Al-Ainy
Consultant in Oncology ,Hematology and Nuclear Medicine, Al-Azhar Medicine
Lecturer Clinical Oncology Faculty of Medicine Alexandria University
Consultant and MD in Oncology and Nuclear Medicine, Cairo University, Kasr Al-Ainy